Physician profile
Cassandre C Charles
NPI 1770143497
$11,683.20
in general payments reported to CMS, 2019-2025
19 companies · $1,409 in 2025
The $1,409 reported for 2025 was more than what 85% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $1,483 · 2021: $2,587 · 2022: $3,542 · 2023: $1,486 · 2024: $46.74 · 2025: $1,409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,053 · Food and Beverage: $857 · Gift: $32.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,053.37 |
| Food and Beverage | $856.67 |
| Gift | $32.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $6,111.36 | 2019-2022 | |
| Medline Industries LP | $1,236.40 | 2023 | |
| Treace Medical Concepts, INC. | $1,228.83 | 2025 | |
| Stryker Corporation | $1,147.39 | 2019-2022 | |
| Medical Device Business Services, INC. | $699.07 | 2022 | |
| Bioventus LLC | $181.99 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $147.96 | 2021-2022 | |
| Medtronic, INC. | $130.15 | 2025 | Inceptiv |
| Innovation Technologies INC | $124.99 | 2023 | Irrisept |
| Averitas Pharma INC. | $124.99 | 2023 | Qutenza |
| Orthofix Medical, INC. | $111.93 | 2019 | |
| Abbvie INC. | $110.60 | 2022 | |
| Paratek Pharmaceuticals, INC. | $104.87 | 2022 | |
| Bone Support INC. | $90.04 | 2022 | |
| Amgen INC. | $49.94 | 2025 | Krystexxa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $26.76 | 2022 | |
| Advanced Oxygen Therapy INC. | $25.66 | 2022 | |
| Smith+Nephew, INC. | $18.32 | 2024 | Collagenase Santyl |
| Integra Lifesciences Corporation | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandre Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.